Iqvia Holdings (IQV) Net Shares Issued and Repurchased (2013 - 2019)
Iqvia Holdings' (IQV) quarterly Net Shares Issued and Repurchased came in at $16455.0 in Q4 2019, down 62.25% year-over-year from $43590.0 in Q4 2018, and down 62.25% quarter-over-quarter from $43590.0 in Q4 2018.
Analysis
Iqvia Holdings (IQV) Net Shares Issued and Repurchased (2013 - 2019) Analysis & Trends
Iqvia Holdings has disclosed Net Shares Issued and Repurchased across 7 years of filings, most recently posting $16455.0 for Q4 2019.
- In Q4 2019, Net Shares Issued and Repurchased fell 62.25% year-over-year to $16455.0; the TTM figure through Dec 2019 stood at $16455.0 (down 62.25% YoY), while the FY2019 annual figure was $16455.0, down 62.25% from the prior year.
- Net Shares Issued and Repurchased came in at $16455.0 for Q4 2019 at Iqvia Holdings, down from $43590.0 in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $457365.0 in Q4 2015 to a low of $16455.0 in Q4 2019.
- Average Net Shares Issued and Repurchased over 5 years is $217595.6, with a median of $212891.0 recorded in 2017.
- Year-over-year, Net Shares Issued and Repurchased retreated 20.41% in 2015 and slumped 79.52% in 2018.
- Over 5 years, Net Shares Issued and Repurchased stood at $457365.0 in 2015, then declined by 21.8% to $357677.0 in 2016, then sank by 40.48% to $212891.0 in 2017, then tumbled by 79.52% to $43590.0 in 2018, then sank by 62.25% to $16455.0 in 2019.
- Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $16455.0 in Q4 2019, $43590.0 in Q4 2018, and $212891.0 in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 16,455.00 |
| Dec 31, 2018 | 43,590.00 |
| Dec 31, 2017 | 212,891.00 |
| Dec 31, 2016 | 357,677.00 |
| Dec 31, 2015 | 457,365.00 |
| Dec 31, 2014 | 574,630.00 |
| Dec 31, 2013 | 410,870.00 |